Please use this identifier to cite or link to this item: https://doi.org/10.1186/s12874-020-01059-y
DC FieldValue
dc.titleCoronavirus disease 2019 (COVID-19): an evidence map of medical literature
dc.contributor.authorLIU NAN
dc.contributor.authorChee, M.L.
dc.contributor.authorNiu, C.
dc.contributor.authorPek, P.P.
dc.contributor.authorSiddiqui, F.J.
dc.contributor.authorAnsah, J.P.
dc.contributor.authorMatchar, D.B.
dc.contributor.authorLam, S.S.W.
dc.contributor.authorAbdullah, H.R.
dc.contributor.authorChan, A.
dc.contributor.authorMalhotra, R.
dc.contributor.authorGraves, N.
dc.contributor.authorKoh, M.S.
dc.contributor.authorYoon, S.
dc.contributor.authorHo, A.F.W.
dc.contributor.authorTing, D.S.W.
dc.contributor.authorLow, J.G.H.
dc.contributor.authorOng, M.E.H.
dc.date.accessioned2020-08-31T01:01:02Z
dc.date.available2020-08-31T01:01:02Z
dc.date.issued2020-07-30
dc.identifier.citationLIU NAN, Chee, M.L., Niu, C., Pek, P.P., Siddiqui, F.J., Ansah, J.P., Matchar, D.B., Lam, S.S.W., Abdullah, H.R., Chan, A., Malhotra, R., Graves, N., Koh, M.S., Yoon, S., Ho, A.F.W., Ting, D.S.W., Low, J.G.H., Ong, M.E.H. (2020-07-30). Coronavirus disease 2019 (COVID-19): an evidence map of medical literature. BMC Medical Research Methodology 20 (1) : 177. ScholarBank@NUS Repository. https://doi.org/10.1186/s12874-020-01059-y
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/173625
dc.description.abstractBackground: Since the beginning of the COVID-19 outbreak in December 2019, a substantial body of COVID-19 medical literature has been generated. As of June 2020, gaps and longitudinal trends in the COVID-19 medical literature remain unidentified, despite potential benefits for research prioritisation and policy setting in both the COVID-19 pandemic and future large-scale public health crises. Methods: In this paper, we searched PubMed and Embase for medical literature on COVID-19 between 1 January and 24 March 2020. We characterised the growth of the early COVID-19 medical literature using evidence maps and bibliometric analyses to elicit cross-sectional and longitudinal trends and systematically identify gaps. Results: The early COVID-19 medical literature originated primarily from Asia and focused mainly on clinical features and diagnosis of the disease. Many areas of potential research remain underexplored, such as mental health, the use of novel technologies and artificial intelligence, pathophysiology of COVID-19 within different body systems, and indirect effects of COVID-19 on the care of non-COVID-19 patients. Few articles involved research collaboration at the international level (24.7%). The median submission-to-publication duration was 8 days (interquartile range: 4–16). Conclusions: Although in its early phase, COVID-19 research has generated a large volume of publications. However, there are still knowledge gaps yet to be filled and areas for improvement for the global research community. Our analysis of early COVID-19 research may be valuable in informing research prioritisation and policy planning both in the current COVID-19 pandemic and similar global health crises.
dc.description.urihttps://bmcmedresmethodol.biomedcentral.com/articles/10.1186/s12874-020-01059-y
dc.language.isoen
dc.publisherSpringer Nature
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectCOVID-19
dc.subjectSARS-CoV-2
dc.subjectCoronavirus disease 2019
dc.subjectReview
dc.subjectSystematic review
dc.subjectEvidence-based medicine
dc.typeArticle
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.doi10.1186/s12874-020-01059-y
dc.description.sourcetitleBMC Medical Research Methodology
dc.description.volume20
dc.description.issue1
dc.description.page177
dc.published.statePublished
Appears in Collections:Staff Publications
Staff Publications
Elements
Students Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
J2020_COVID_EGM_BMC.pdf1.58 MBAdobe PDF

OPEN

PublishedView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons